CAPITAL

MARKETS Day 2023

DISCLAIMER

CAUTIONARY REGARDING FORWARD-LOOKING STATEMENTS

  • We may make statements that are not historical facts and relate to analyses and other information based on forecasts of future results and estimates of amounts not yet determinable. These are forward looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Words such as "prospects", "believe", "anticipate", "expect", "intend", "seek", "will", "plan", "indicate", "could", "may", "endeavour" and "project" and similar expressions are intended to identify such forward looking statements but are not the exclusive means of identifying such statements. By their very nature, forward-looking statements involve inherent risks and uncertainties, both general and specific, and there are risks that predictions, forecasts, projections and other forward-looking statements will not be achieved. If one or more of these risks materialise, or should underlying assumptions prove incorrect, actual results may be very different from those anticipated. The factors that could cause our actual results to differ materially from the plans, objectives, expectations, estimates and intentions expressed in such forward-looking statements are discussed in each year's annual report. ​​
  • Forward looking statements apply only as of the date on which they are made, and we do not undertake, other than in terms of the Listings Requirements of the JSE Limited, any obligation to update or revise any of them, whether as a result of new information, future events or otherwise. Any profit forecasts published in this report are unaudited and have not been reviewed or reported on by Aspen's external auditors. ​

2

BACKGROUND AND OBJECTIVE

ASPEN'S STRATEGIC JOURNEY IN STERILE MANUFACTURING

Vision For Sterile Manufacturing

8 YEARS IN THE MAKING

Sustainable demand

Future shift towards biologicals

First mover

and other advanced sterile

strategic advantage

technologies.

Opportunity to increase

Vertical integration paybackpatient access to steriles in Africa.

High barriers to entry

INVESTING NOW WOULD BE LATE

AREAS OF INVESTMENT

  • Prefilled syringes
  • Anaesthetics
  • Vaccines & biologicals
  • Vials, Cartridges & BFS

7

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Aspen Pharmacare Holdings Ltd. published this content on 29 November 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 29 November 2023 07:33:15 UTC.